Marc L Hoffman

Insider

First SEC filing: Nov. 27, 2019 · Latest: Nov. 27, 2019

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 17, 2023	RMTI	A	32,990	—	—	32,990 Direct	—	Acquired	(price as of 2026-08-19)
March 17, 2023	RMTI	A	25,665	—	—	25,665 Direct	—	Acquired	(price as of 2026-08-19)
Sept. 9, 2022	RMTI	A	60,000	—	—	60,000 Direct	—	Acquired	(price as of 2026-08-19)
Nov. 25, 2019	RMTI	A	250,000	—	—	250,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 17, 2023	RMTI	Stock Option (Right to Buy)	Common Stock (32,990)	$1.37	March 17, 2033	32,990	Acquired
Sept. 9, 2022	RMTI	Stock Option (Right to Buy)	Common Stock (60,000)	$1.66	Sept. 9, 2032	60,000	Acquired
Nov. 25, 2019	RMTI	Stock Option (Right to Buy)	Common Stock (250,000)	$2.18	Nov. 25, 2029	250,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Chief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2022	$401,250	—	—	$66,900	$106,733	—	$11,729	$586,612

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.